financetom
Business
financetom
/
Business
/
Fulton Financial Insider Sold Shares Worth $275,635, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fulton Financial Insider Sold Shares Worth $275,635, According to a Recent SEC Filing
Jan 27, 2025 1:55 PM

04:19 PM EST, 01/27/2025 (MT Newswires) -- Angela M Snyder, President, on January 27, 2025, sold 13,322 shares in Fulton Financial ( FULT ) for $275,635. Following the Form 4 filing with the SEC, Snyder has control over a total of 63,682 shares of the company, with 63,682 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/700564/000156218025000529/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Wright Flood Completes The Acquisition Of Poulton Associates
BRIEF-Wright Flood Completes The Acquisition Of Poulton Associates
Nov 4, 2025
Nov 4 (Reuters) - Brown & Brown Inc ( BRO ): * WRIGHT FLOOD COMPLETES THE ACQUISITION OF POULTON ASSOCIATES, LLC Source text: Further company coverage: ...
InspireMD Q3 revenue beats estimates on commercial launch of CGuard Prime
InspireMD Q3 revenue beats estimates on commercial launch of CGuard Prime
Nov 4, 2025
Overview * InspireMD ( NSPR ) Q3 revenue grows 39% yr/yr, beating analyst expectations * Net income for Q3 beats analyst estimates despite larger net loss * Company attributes revenue growth to U.S. launch and international market penetration Outlook * InspireMD ( NSPR ) highlights strong demand for its CGuard Prime globally * Company emphasizes strategic focus on U.S. commercial...
Neuronetics Q3 revenue misses estimates
Neuronetics Q3 revenue misses estimates
Nov 4, 2025
Overview * Neuronetics Q3 2025 revenue rose 101% yr/yr but missed analyst expectations * U.S. Greenbrook clinic revenue grew 25% on an adjusted pro forma basis * CEO Keith J. Sullivan to retire in June 2026, search for successor underway Outlook * Company expects Q4 2025 revenue between $40 mln and $43 mln * Neuronetics ( STIM ) revises 2025...
Sotera Health beats Q3 estimates, raises FY profit guidance
Sotera Health beats Q3 estimates, raises FY profit guidance
Nov 4, 2025
Overview * Sotera Health ( SHC ) Q3 revenue rose 9.1% to $311 mln, beating analyst expectations * Adjusted EPS for Q3 increased to $0.26, surpassing analyst estimates * Adjusted EBITDA for Q3 rose 12.2% to $164 mln, exceeding expectations Outlook * Sotera Health ( SHC ) raises 2025 Adjusted EBITDA growth range to 6.75%-7.75% * Company reaffirms 2025 net...
Copyright 2023-2026 - www.financetom.com All Rights Reserved